Iridex (IRIX) Liabilities and Shareholders Equity (2011 - 2026)
Iridex (IRIX) posted quarterly Liabilities and Shareholders Equity of $28.3 million for Q2 2026, down 17.41% year-over-year from $34.2 million in Q2 2025, and down 3.01% quarter-over-quarter from $29.2 million in Q1 2026.
Iridex (IRIX) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Iridex's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $28.3 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 17.41% year-over-year to $28.3 million; the TTM figure through Apr 2026 stood at $117.4 million (down 5.94% YoY), while the FY2026 annual figure was $29.2 million, changed 0.05% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $28.3 million, down from $29.2 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $48.7 million in Q1 2022, with the low at $28.3 million in Q2 2026.
- The 5-year median for Liabilities and Shareholders Equity is $34.3 million (2023), against an average of $36.3 million.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity soared 74.07% in 2022, then decreased 22.26% in 2023.
- Iridex's Liabilities and Shareholders Equity stood at $42.3 million in 2022, then slipped by 18.57% to $34.4 million in 2023, then dropped by 15.39% to $29.1 million in 2024, then decreased by 2.68% to $28.4 million in 2025, then fell by 0.28% to $28.3 million in 2026.
- Business Quant data shows IRIX's Liabilities and Shareholders Equity at $28.3 million in Q2 2026, $29.2 million in Q1 2026, and $28.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Iridex | 13.41 Mn | 8.73 Mn | 4.30 Mn | 27.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 28.27 Mn |
| Jan 3, 2026 | 29.15 Mn |
| Sep 27, 2025 | 28.35 Mn |
| Jun 28, 2025 | 31.59 Mn |
| Mar 29, 2025 | 34.24 Mn |
| Dec 28, 2024 | 29.14 Mn |
| Sep 28, 2024 | 30.15 Mn |
| Jun 29, 2024 | 31.25 Mn |
| Mar 30, 2024 | 34.09 Mn |
| Dec 30, 2023 | 34.44 Mn |
| Sep 30, 2023 | 34.95 Mn |
| Jul 1, 2023 | 36.94 Mn |
| Apr 1, 2023 | 40.98 Mn |
| Dec 31, 2022 | 42.29 Mn |
| Oct 1, 2022 | 44.96 Mn |
| Jul 2, 2022 | 45.65 Mn |
| Apr 2, 2022 | 48.02 Mn |
| Jan 1, 2022 | 48.69 Mn |
| Oct 2, 2021 | 50.54 Mn |
| Jul 3, 2021 | 50.52 Mn |